“Are women interested in a nonhormonal multipurpose prevention technology (MPT) vaginal ring? Results from a national online survey with U.S. women” (Abstract)
Ann Gottert*, S. Mathur, T. Abuya, I. Bruce, S. Shetty, M. Nguyen, J.M. Sales, L.B. Haddad, and B.A. Friedland
“Comparison of self-reported, pill count and biomarker measures of adherence to oral PrEP or a dual prevention pill in crossover clinical trial in Harare, Zimbabwe” (Abstract)
Marlena Plagianos*, N.M. Mgodi, B. Zieman, S. Mathur, I. Bruce, A. Dandadzi, P. Musara, C. Murombedzi, L. Haddad, and B. Friedland
“Development of a multipurpose intravaginal ring for controlled release of Q-Griffithsin combined with contraceptive hormones: In vitro and in vivo evaluation” (Abstract)
M.M. Baum, M. Gunawardana, J. Breslin, I. Butkyavichene, A.E. Castonguay, D.B. Diener, S. Gunawardana, M. Remedios-Chan, J.A. Moss, P. Barnable, T. Bonnaire, J. Fernandez-Romero, M. Aravantinou, F. Schiro, B. Grasperge, N. Derby, P. Angsantikul, N. Kumar, B. Variano, and Natalia Teleshova*
“Preference for and adherence to a dual prevention pill (DPP) versus two separate pills for PrEP and contraception among women in Johannesburg, South Africa” (Abstract)
B. Zieman, Marlena Plagianos*, T. Palanee, S. Reddy, N. Ndlovu, S. Zulu, I. Bruce, S. Mathur, L. Shale, L.B. Haddad, and B. Friedland
“Safety/pharmacokinetics/pharmacodynamics and immunogenicity studies of Griffithsin fast dissolving insert in rhesus macaques” (Abstract)
P. Barnable, M.L. Visciano, M. Aravantinou, N. Kommineni, J. Gadsden, F. Schiro, L. Guzmán, B. Grasperge, P. Angsantikul, J. Fernandez-Romero, L.B. Haddad, and Natalia Teleshova*